Subsequently, PRAME was found to be expressed in several other cancers [51,52,53,54] and high PRAME expression was demonstrated to be an independent prognostic marker for poor outcomes in breast cancer and neuroblastoma [52,53]. This evidence concerns the gene PRAME and breast cancer.